8-K – Page 707 – China Stock Advice

SYUT [Synutra International] 8-K: ITEM 6. SELECTED FINANCIAL DATA In July 2005,

[ITEM 6. SELECTED FINANCIAL DATA In July 2005, we changed our fiscal year end from December 31 to March 31 beginning with the fiscal year ended March 31, 2005. The following selected consolidated financial data for the fiscal years ended March 31, 2009, 2008 and 2007 are derived from our audited consolidated financial statements included elsewhere in this Form 10-K.] [FORM 8-K CURRENT REPORT November 5th, 2009 Date of Report (Date of earliest event reported): SYNUTRA INTERNATIONAL, INC. Delaware 001-33397 13-4306188 (State or other jurisdiction of incorporation) (Commission (IRS Employer Identification No.) 2275 Research Blvd., Suite 500, Rockville, MD 20850 (ZIP Code) (301) 840-3888 N/A (Former name or former address, if changed since last report) o o o o Item]

By info| 2016-03-18T21:08:08+00:00 November 5th, 2009|Categories: Chinese Stocks, SYUT, Webplus ver|Tags: 0001293593, 2009-11-05, 2020, 8-K, DAIRY PRODUCTS, SYUT|0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL] 8-K: (Original Filing)

[Skystar Bio-Pharmaceuticalmpany Announces Two-for-One Stocklit XI'AN, CHINA November 5, 2009ystar Bio-Pharmaceuticalmpany (NASDAQ:BI) Shareholders of record of the close of market on November 16, 2009 will automatically be entitled to oneditional share ofmmon stock for each share owned. No action is required on the part of the shareholders, thempanys transferent willd thelit-adjusted shares to its records.]

By info| 2016-02-05T04:57:43+00:00 November 5th, 2009|Categories: Chinese Stocks, SEC Original, SKBI|Tags: 0001076939, 2009-11-05, 2834, 8-K, PHARMACEUTICAL PREPARATIONS, SKBI|0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL] 8-K: Skystar Bio-Pharmaceuticalmpany Announces Two-for-One Stocklit XI’AN, CHINA November

[Skystar Bio-Pharmaceuticalmpany Announces Two-for-One Stocklit XI'AN, CHINA November 5, 2009ystar Bio-Pharmaceuticalmpany (NASDAQ:BI) Shareholders of record of the close of market on November 16, 2009 will automatically be entitled to oneditional share ofmmon stock for each share owned. No action is required on the part of the shareholders, thempanys transferent willd thelit-adjusted shares to its records.]

By info| 2016-02-05T04:58:15+00:00 November 5th, 2009|Categories: Chinese Stocks, SKBI, Webplus ver|Tags: 0001076939, 2009-11-05, 2834, 8-K, PHARMACEUTICAL PREPARATIONS, SKBI|0 Comments

SYUT [Synutra International] 8-K: (Original Filing)

[ITEM 6. SELECTED FINANCIAL DATA In July 2005, we changed our fiscal year end from December 31 to March 31 beginning with the fiscal year ended March 31, 2005. The following selected consolidated financial data for the fiscal years ended March 31, 2009, 2008 and 2007 are derived from our audited consolidated financial statements included elsewhere in this Form 10-K.] [FORM 8-K CURRENT REPORT November 5th, 2009 Date of Report (Date of earliest event reported): SYNUTRA INTERNATIONAL, INC. Delaware 001-33397 13-4306188 (State or other jurisdiction of incorporation) (Commission (IRS Employer Identification No.) 2275 Research Blvd., Suite 500, Rockville, MD 20850 (ZIP Code) (301) 840-3888 N/A (Former name or former address, if changed since last report) o o o o Item]

By info| 2016-03-18T21:07:07+00:00 November 5th, 2009|Categories: Chinese Stocks, SEC Original, SYUT|Tags: 0001293593, 2009-11-05, 2020, 8-K, DAIRY PRODUCTS, SYUT|0 Comments

BSPM [Biostar Pharmaceuticals,] 8-K: (Original Filing)

[ARTICLES SUPPLEMENTARY TO THE ARTICLES OF INCORPOATION OF BIOSTAR PHARMACEUTICALS, INC. Biostar Pharmaceuticals, Inc., a corporation organized and existing under the laws of the State of Maryland (the “Corporation”), hereby certifies to the State Department of Assessments and Taxation of Maryland, that: Annex A SECOND: A description of the shares so classified with the preferences, conversions and other rights, voting] [--------------------------------------- BIOSTAR PHARMACEUTICALS, INC. Number of Shares: Holder: Exercise Price per Share: $3.00 Company Purchase Agreement Common Stock Exercise Price Expiration Date The Company hereby certifies that, for value received, __________, or registered assigns (the “ 1. . 2. Investment Representation . Person 3. . 4. a. b. 5. a. b. Date of Exercise A “ c. d. Net Number] [SECURITIES PURCHASE AGREEMENT SECURITIES PURCHASE AGREEMENT Agreement Company Buyer Buyers Parties Party BACKGROUND WHEREAS 1933 Act Regulation D SEC WHEREAS Series B Preferred Stock Common Stock Securities WHEREAS Escrow Agent Closing Escrow Agreement WHEREAS Make Good Escrow Agent Make Good Escrow Agreement WHEREAS NOW, THEREFORE Article 1 INCORPORATION BY REFERENCE AND DEFINITIONS 1.1 Incorporation by Reference 1.2 Supersedes Other Agreements] [MAKE GOOD ESCROW AGREEMENT Agreement Company Purchasers Purchaser Escrow Agent Escrowing Parties This Agreement, dated as of November 2, 2009 (this “ WITNESSETH: WHEREAS Purchase Agreement ) Series B Preferred Stock Common Stock Securities Purchase Price WHEREAS WHEREAS NOW, THEREFORE, in consideration of the mutual promises herein contained and intending to be legally bound, the parties hereby agree as follows:] [CLOSING ESCROW AGREEMENT Agreement Company Purchasers Purchaser Escrow Agent Escrowing Parties This Agreement, dated as of November 2, 2009 (this “ WITNESSETH: WHEREAS Purchase Agreement ) Series B Preferred Stock Common Stock Securities Purchase Price WHEREAS Escrowed Funds WHEREAS NOW, THEREFORE, in consideration of the mutual promises herein contained and intending to be legally bound, the parties hereby agree as]

By info| 2016-03-03T15:41:25+00:00 November 3rd, 2009|Categories: BSPM, Chinese Stocks, SEC Original|Tags: 0001418133, 2009-11-03, 2834, 8-K, BSPM, PHARMACEUTICAL PREPARATIONS|0 Comments

BSPM [Biostar Pharmaceuticals,] 8-K: ARTICLES SUPPLEMENTARY TO THE ARTICLES OF INCORPOATION OF

[ARTICLES SUPPLEMENTARY TO THE ARTICLES OF INCORPOATION OF BIOSTAR PHARMACEUTICALS, INC. Biostar Pharmaceuticals, Inc., a corporation organized and existing under the laws of the State of Maryland (the “Corporation”), hereby certifies to the State Department of Assessments and Taxation of Maryland, that: Annex A SECOND: A description of the shares so classified with the preferences, conversions and other rights, voting] [--------------------------------------- BIOSTAR PHARMACEUTICALS, INC. Number of Shares: Holder: Exercise Price per Share: $3.00 Company Purchase Agreement Common Stock Exercise Price Expiration Date The Company hereby certifies that, for value received, __________, or registered assigns (the “ 1. . 2. Investment Representation . Person 3. . 4. a. b. 5. a. b. Date of Exercise A “ c. d. Net Number] [SECURITIES PURCHASE AGREEMENT SECURITIES PURCHASE AGREEMENT Agreement Company Buyer Buyers Parties Party BACKGROUND WHEREAS 1933 Act Regulation D SEC WHEREAS Series B Preferred Stock Common Stock Securities WHEREAS Escrow Agent Closing Escrow Agreement WHEREAS Make Good Escrow Agent Make Good Escrow Agreement WHEREAS NOW, THEREFORE Article 1 INCORPORATION BY REFERENCE AND DEFINITIONS 1.1 Incorporation by Reference 1.2 Supersedes Other Agreements] [MAKE GOOD ESCROW AGREEMENT Agreement Company Purchasers Purchaser Escrow Agent Escrowing Parties This Agreement, dated as of November 2, 2009 (this “ WITNESSETH: WHEREAS Purchase Agreement ) Series B Preferred Stock Common Stock Securities Purchase Price WHEREAS WHEREAS NOW, THEREFORE, in consideration of the mutual promises herein contained and intending to be legally bound, the parties hereby agree as follows:] [CLOSING ESCROW AGREEMENT Agreement Company Purchasers Purchaser Escrow Agent Escrowing Parties This Agreement, dated as of November 2, 2009 (this “ WITNESSETH: WHEREAS Purchase Agreement ) Series B Preferred Stock Common Stock Securities Purchase Price WHEREAS Escrowed Funds WHEREAS NOW, THEREFORE, in consideration of the mutual promises herein contained and intending to be legally bound, the parties hereby agree as]

By info| 2016-03-03T15:44:13+00:00 November 3rd, 2009|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: 0001418133, 2009-11-03, 2834, 8-K, BSPM, PHARMACEUTICAL PREPARATIONS|0 Comments

SYUT [Synutra International] 8-K: (Original Filing)

[Synutra International, Inc. Announces Appointment of Interim Chief Financial Officer QINGDAO, China & ROCKVILLE, Md.--(BUSINESS WIRE)--November 2, 2009--Synutra International, Inc. (NASDAQ: SYUT; “Synutra”), a leading infant formula company in China and a producer, marketer and seller of nutritional products for infants, children and adults, today announced the appointment of Joseph Chow as interim chief financial officer in place of Lawrence] [Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On November 2, 2009 Lawrence Lee, Chief Financial Officer (“CFO”) of Synutra International, Inc. (the “Company”), tendered his resignation as CFO to be effective November 10, 2009. On November 2, 2009, the Company appointed Joseph Chow as the interim CFO]

By info| 2016-03-18T21:09:38+00:00 November 2nd, 2009|Categories: Chinese Stocks, SEC Original, SYUT|Tags: 0001293593, 2009-11-02, 2020, 8-K, DAIRY PRODUCTS, SYUT|0 Comments

SYUT [Synutra International] 8-K: Synutra International, Inc. Announces Appointment of Interim Chief

[Synutra International, Inc. Announces Appointment of Interim Chief Financial Officer QINGDAO, China & ROCKVILLE, Md.--(BUSINESS WIRE)--November 2, 2009--Synutra International, Inc. (NASDAQ: SYUT; “Synutra”), a leading infant formula company in China and a producer, marketer and seller of nutritional products for infants, children and adults, today announced the appointment of Joseph Chow as interim chief financial officer in place of Lawrence] [Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On November 2, 2009 Lawrence Lee, Chief Financial Officer (“CFO”) of Synutra International, Inc. (the “Company”), tendered his resignation as CFO to be effective November 10, 2009. On November 2, 2009, the Company appointed Joseph Chow as the interim CFO]

By info| 2016-03-18T21:10:33+00:00 November 2nd, 2009|Categories: Chinese Stocks, SYUT, Webplus ver|Tags: 0001293593, 2009-11-02, 2020, 8-K, DAIRY PRODUCTS, SYUT|0 Comments

CLNT [Cleantech Solutions International] 8-K: (Original Filing)

[China Wind Systems, Inc. No. 9 Yanyu Middle Road Qianzhou Village, Huishan District, Wuxi City Jiangsu Province, Peoples Republic of China Subscription Agreement Re: Gentlemen: 1.The Company is offering 2,400,000 Shares at a purchase price of $1.00 per share on a best efforts basis, with no minimum number of Shares being sold.As a result, the], [China Wind Systems, Inc. No. 9 Yanyu Middle Road Qianzhou Village, Huishan District, Wuxi City Jiangsu Province, Peoples Republic of China Subscription Agreement Re: Gentlemen: 1.The Company is offering 2,400,000 Shares at a purchase price of $1.00 per share on a best efforts basis, with no minimum number of Shares being sold.As a result, the], [VOTING AGREEMENT WITNESSETH: Agreement to Vote 1. (a)Barron hereby agrees that at any meeting of the stockholders of the Company, however called, and in any action by consent of the stockholders of the Company, with regards to the Covered Shares, Barron shall vote or cause to be voted or execute a written consent in favor]

By info| 2016-01-10T01:43:03+00:00 October 26th, 2009|Categories: Chinese Stocks, CLNT, SEC Original|Tags: 0000819926, 2009-10-26, 3550, 8-K, CLNT, SPECIAL INDUSTRY MACHINERY (NO METALWORKING MACHINERY)|0 Comments

RCON [Recon Technology] 8-K: ANSEN ARNETT AXWELL P C H A Professional

[ANSEN ARNETT AXWELL P C H A Professional Corporation CERTIFIED PUBLIC ACCOUNTANTS 5 Triad Center, Suite 750 Salt Lake City, UT 84180-1128 Phone: (801) 532-2200 Fax: (801) 532-7944 www.hbmcpas.com Registered with the Public Company Accounting Oversight Board A Member of the Forum of Firms October 19, 2009 100 F Street, N.E. Gentlemen: We have read Item 4.01 of Form 8-K] [Recon Technology Announces Engagement of Bernstein & Pinchuk LLP as Auditor Beijing, China October 19, 2009 We have had a positive relationship with HBM and appreciate their dedicated services, said Shenping Yin, the CEO of Recon Technology, Moving forward, the board has determined that Bernstein & Pinchuk offers our shareholders a strong combination of quality services, experience working with] []

By info| 2016-03-13T08:32:07+00:00 October 19th, 2009|Categories: Chinese Stocks, RCON, Webplus ver|Tags: 0001442620, 1389, 2009-10-19, 8-K, OIL, GAS FIELD SERVICES, NBC, RCON|0 Comments